<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d21" origId="Ketorolac"><sentence id="DrugDDI.d21.s0" origId="s0" text="Ketorolac is highly bound to human plasma protein (mean 99.2%)."><entity charOffset="0-9" id="DrugDDI.d21.s0.e0" origId="s0.p0" text="Ketorolac" type="drug"/><entity charOffset="35-49" id="DrugDDI.d21.s0.e1" origId="s0.p4" text="plasma protein" type="drug"/><pair e1="DrugDDI.d21.s0.e0" e2="DrugDDI.d21.s0.e1" id="DrugDDI.d21.s0.p0" interaction="false"/></sentence><sentence id="DrugDDI.d21.s1" origId="s1" text="Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL."><entity charOffset="0-8" id="DrugDDI.d21.s1.e0" origId="s1.p8" text="Warfarin" type="drug"/><entity charOffset="10-17" id="DrugDDI.d21.s1.e1" origId="s1.p9" text="Digoxin" type="drug"/><entity charOffset="19-29" id="DrugDDI.d21.s1.e2" origId="s1.p10" text="Salicylate" type="drug"/><entity charOffset="67-75" id="DrugDDI.d21.s1.e3" origId="s1.p13" text="warfarin" type="drug"/><entity charOffset="79-94" id="DrugDDI.d21.s1.e4" origId="s1.p14" text="plasma proteins" type="drug"/><entity charOffset="123-145" id="DrugDDI.d21.s1.e5" origId="s1.p18" text="ketorolac tromethamine" type="drug"/><entity charOffset="176-185" id="DrugDDI.d21.s1.e6" origId="s1.p25" text="ketorolac" type="drug"/><entity charOffset="214-221" id="DrugDDI.d21.s1.e7" origId="s1.p27" text="5 to10" type="drug"/><pair e1="DrugDDI.d21.s1.e0" e2="DrugDDI.d21.s1.e1" id="DrugDDI.d21.s1.p0" interaction="false"/><pair e1="DrugDDI.d21.s1.e0" e2="DrugDDI.d21.s1.e2" id="DrugDDI.d21.s1.p1" interaction="false"/><pair e1="DrugDDI.d21.s1.e0" e2="DrugDDI.d21.s1.e3" id="DrugDDI.d21.s1.p2" interaction="false"/><pair e1="DrugDDI.d21.s1.e0" e2="DrugDDI.d21.s1.e4" id="DrugDDI.d21.s1.p3" interaction="false"/><pair e1="DrugDDI.d21.s1.e0" e2="DrugDDI.d21.s1.e5" id="DrugDDI.d21.s1.p4" interaction="false"/><pair e1="DrugDDI.d21.s1.e0" e2="DrugDDI.d21.s1.e6" id="DrugDDI.d21.s1.p5" interaction="false"/><pair e1="DrugDDI.d21.s1.e0" e2="DrugDDI.d21.s1.e7" id="DrugDDI.d21.s1.p6" interaction="false"/><pair e1="DrugDDI.d21.s1.e1" e2="DrugDDI.d21.s1.e2" id="DrugDDI.d21.s1.p7" interaction="false"/><pair e1="DrugDDI.d21.s1.e1" e2="DrugDDI.d21.s1.e3" id="DrugDDI.d21.s1.p8" interaction="false"/><pair e1="DrugDDI.d21.s1.e1" e2="DrugDDI.d21.s1.e4" id="DrugDDI.d21.s1.p9" interaction="false"/><pair e1="DrugDDI.d21.s1.e1" e2="DrugDDI.d21.s1.e5" id="DrugDDI.d21.s1.p10" interaction="false"/><pair e1="DrugDDI.d21.s1.e1" e2="DrugDDI.d21.s1.e6" id="DrugDDI.d21.s1.p11" interaction="false"/><pair e1="DrugDDI.d21.s1.e1" e2="DrugDDI.d21.s1.e7" id="DrugDDI.d21.s1.p12" interaction="false"/><pair e1="DrugDDI.d21.s1.e2" e2="DrugDDI.d21.s1.e3" id="DrugDDI.d21.s1.p13" interaction="false"/><pair e1="DrugDDI.d21.s1.e2" e2="DrugDDI.d21.s1.e4" id="DrugDDI.d21.s1.p14" interaction="false"/><pair e1="DrugDDI.d21.s1.e2" e2="DrugDDI.d21.s1.e5" id="DrugDDI.d21.s1.p15" interaction="false"/><pair e1="DrugDDI.d21.s1.e2" e2="DrugDDI.d21.s1.e6" id="DrugDDI.d21.s1.p16" interaction="false"/><pair e1="DrugDDI.d21.s1.e2" e2="DrugDDI.d21.s1.e7" id="DrugDDI.d21.s1.p17" interaction="false"/><pair e1="DrugDDI.d21.s1.e3" e2="DrugDDI.d21.s1.e4" id="DrugDDI.d21.s1.p18" interaction="false"/><pair e1="DrugDDI.d21.s1.e3" e2="DrugDDI.d21.s1.e5" id="DrugDDI.d21.s1.p19" interaction="true"/><pair e1="DrugDDI.d21.s1.e3" e2="DrugDDI.d21.s1.e6" id="DrugDDI.d21.s1.p20" interaction="false"/><pair e1="DrugDDI.d21.s1.e3" e2="DrugDDI.d21.s1.e7" id="DrugDDI.d21.s1.p21" interaction="false"/><pair e1="DrugDDI.d21.s1.e4" e2="DrugDDI.d21.s1.e5" id="DrugDDI.d21.s1.p22" interaction="false"/><pair e1="DrugDDI.d21.s1.e4" e2="DrugDDI.d21.s1.e6" id="DrugDDI.d21.s1.p23" interaction="false"/><pair e1="DrugDDI.d21.s1.e4" e2="DrugDDI.d21.s1.e7" id="DrugDDI.d21.s1.p24" interaction="false"/><pair e1="DrugDDI.d21.s1.e5" e2="DrugDDI.d21.s1.e6" id="DrugDDI.d21.s1.p25" interaction="false"/><pair e1="DrugDDI.d21.s1.e5" e2="DrugDDI.d21.s1.e7" id="DrugDDI.d21.s1.p26" interaction="false"/><pair e1="DrugDDI.d21.s1.e6" e2="DrugDDI.d21.s1.e7" id="DrugDDI.d21.s1.p27" interaction="false"/></sentence><sentence id="DrugDDI.d21.s2" origId="s2" text="Ketorolac does not alter digoxin protein binding."><entity charOffset="0-9" id="DrugDDI.d21.s2.e0" origId="s2.p29" text="Ketorolac" type="drug"/><entity charOffset="25-32" id="DrugDDI.d21.s2.e1" origId="s2.p33" text="digoxin" type="drug"/><pair e1="DrugDDI.d21.s2.e0" e2="DrugDDI.d21.s2.e1" id="DrugDDI.d21.s2.p0" interaction="false"/><negationtags>Ketorolac does &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; alter digoxin protein binding&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d21.s3" origId="s3" text="In vitro studies indicate that, at therapeutic concentrations of salicylate (300 m g/mL), the binding of ketorolac was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound ketorolac plasma levels."><entity charOffset="65-75" id="DrugDDI.d21.s3.e0" origId="s3.p38" text="salicylate" type="drug"/><entity charOffset="105-114" id="DrugDDI.d21.s3.e1" origId="s3.p45" text="ketorolac" type="drug"/><entity charOffset="215-224" id="DrugDDI.d21.s3.e2" origId="s3.p52" text="ketorolac" type="drug"/><pair e1="DrugDDI.d21.s3.e0" e2="DrugDDI.d21.s3.e1" id="DrugDDI.d21.s3.p0" interaction="true"/><pair e1="DrugDDI.d21.s3.e0" e2="DrugDDI.d21.s3.e2" id="DrugDDI.d21.s3.p1" interaction="false"/><pair e1="DrugDDI.d21.s3.e1" e2="DrugDDI.d21.s3.e2" id="DrugDDI.d21.s3.p2" interaction="false"/></sentence><sentence id="DrugDDI.d21.s4" origId="s4" text="Therapeutic concentrations of digoxin, warfarin, ibuprofen, naproxen, piroxicam, acetaminophen, phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding."><entity charOffset="30-37" id="DrugDDI.d21.s4.e0" origId="s4.p54" text="digoxin" type="drug"/><entity charOffset="39-47" id="DrugDDI.d21.s4.e1" origId="s4.p55" text="warfarin" type="drug"/><entity charOffset="49-58" id="DrugDDI.d21.s4.e2" origId="s4.p56" text="ibuprofen" type="drug"/><entity charOffset="60-68" id="DrugDDI.d21.s4.e3" origId="s4.p57" text="naproxen" type="drug"/><entity charOffset="70-79" id="DrugDDI.d21.s4.e4" origId="s4.p58" text="piroxicam" type="drug"/><entity charOffset="81-94" id="DrugDDI.d21.s4.e5" origId="s4.p59" text="acetaminophen" type="drug"/><entity charOffset="96-105" id="DrugDDI.d21.s4.e6" origId="s4.p60" text="phenytoin" type="drug"/><entity charOffset="135-157" id="DrugDDI.d21.s4.e7" origId="s4.p64" text="ketorolac tromethamine" type="drug"/><pair e1="DrugDDI.d21.s4.e0" e2="DrugDDI.d21.s4.e1" id="DrugDDI.d21.s4.p0" interaction="false"/><pair e1="DrugDDI.d21.s4.e0" e2="DrugDDI.d21.s4.e2" id="DrugDDI.d21.s4.p1" interaction="false"/><pair e1="DrugDDI.d21.s4.e0" e2="DrugDDI.d21.s4.e3" id="DrugDDI.d21.s4.p2" interaction="false"/><pair e1="DrugDDI.d21.s4.e0" e2="DrugDDI.d21.s4.e4" id="DrugDDI.d21.s4.p3" interaction="false"/><pair e1="DrugDDI.d21.s4.e0" e2="DrugDDI.d21.s4.e5" id="DrugDDI.d21.s4.p4" interaction="false"/><pair e1="DrugDDI.d21.s4.e0" e2="DrugDDI.d21.s4.e6" id="DrugDDI.d21.s4.p5" interaction="false"/><pair e1="DrugDDI.d21.s4.e0" e2="DrugDDI.d21.s4.e7" id="DrugDDI.d21.s4.p6" interaction="false"/><pair e1="DrugDDI.d21.s4.e1" e2="DrugDDI.d21.s4.e2" id="DrugDDI.d21.s4.p7" interaction="false"/><pair e1="DrugDDI.d21.s4.e1" e2="DrugDDI.d21.s4.e3" id="DrugDDI.d21.s4.p8" interaction="false"/><pair e1="DrugDDI.d21.s4.e1" e2="DrugDDI.d21.s4.e4" id="DrugDDI.d21.s4.p9" interaction="false"/><pair e1="DrugDDI.d21.s4.e1" e2="DrugDDI.d21.s4.e5" id="DrugDDI.d21.s4.p10" interaction="false"/><pair e1="DrugDDI.d21.s4.e1" e2="DrugDDI.d21.s4.e6" id="DrugDDI.d21.s4.p11" interaction="false"/><pair e1="DrugDDI.d21.s4.e1" e2="DrugDDI.d21.s4.e7" id="DrugDDI.d21.s4.p12" interaction="false"/><pair e1="DrugDDI.d21.s4.e2" e2="DrugDDI.d21.s4.e3" id="DrugDDI.d21.s4.p13" interaction="false"/><pair e1="DrugDDI.d21.s4.e2" e2="DrugDDI.d21.s4.e4" id="DrugDDI.d21.s4.p14" interaction="false"/><pair e1="DrugDDI.d21.s4.e2" e2="DrugDDI.d21.s4.e5" id="DrugDDI.d21.s4.p15" interaction="false"/><pair e1="DrugDDI.d21.s4.e2" e2="DrugDDI.d21.s4.e6" id="DrugDDI.d21.s4.p16" interaction="false"/><pair e1="DrugDDI.d21.s4.e2" e2="DrugDDI.d21.s4.e7" id="DrugDDI.d21.s4.p17" interaction="false"/><pair e1="DrugDDI.d21.s4.e3" e2="DrugDDI.d21.s4.e4" id="DrugDDI.d21.s4.p18" interaction="false"/><pair e1="DrugDDI.d21.s4.e3" e2="DrugDDI.d21.s4.e5" id="DrugDDI.d21.s4.p19" interaction="false"/><pair e1="DrugDDI.d21.s4.e3" e2="DrugDDI.d21.s4.e6" id="DrugDDI.d21.s4.p20" interaction="false"/><pair e1="DrugDDI.d21.s4.e3" e2="DrugDDI.d21.s4.e7" id="DrugDDI.d21.s4.p21" interaction="false"/><pair e1="DrugDDI.d21.s4.e4" e2="DrugDDI.d21.s4.e5" id="DrugDDI.d21.s4.p22" interaction="false"/><pair e1="DrugDDI.d21.s4.e4" e2="DrugDDI.d21.s4.e6" id="DrugDDI.d21.s4.p23" interaction="false"/><pair e1="DrugDDI.d21.s4.e4" e2="DrugDDI.d21.s4.e7" id="DrugDDI.d21.s4.p24" interaction="false"/><pair e1="DrugDDI.d21.s4.e5" e2="DrugDDI.d21.s4.e6" id="DrugDDI.d21.s4.p25" interaction="false"/><pair e1="DrugDDI.d21.s4.e5" e2="DrugDDI.d21.s4.e7" id="DrugDDI.d21.s4.p26" interaction="false"/><pair e1="DrugDDI.d21.s4.e6" e2="DrugDDI.d21.s4.e7" id="DrugDDI.d21.s4.p27" interaction="false"/><negationtags>Therapeutic concentrations of digoxin, warfarin, ibuprofen, naproxen, piroxicam, acetaminophen, phenytoin andtolbutamide did &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; alter ketorolac tromethamine protein binding&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d21.s5" origId="s5" text="In a study involving 12 adult volunteers, TORADOLORAL was coadministered with a single dose of 25 mg warfarin, causing no significant changes in pharmacokinetics or pharmacodynamics of warfarin."><entity charOffset="101-109" id="DrugDDI.d21.s5.e0" origId="s5.p72" text="warfarin" type="drug"/><entity charOffset="185-193" id="DrugDDI.d21.s5.e1" origId="s5.p78" text="warfarin" type="drug"/><pair e1="DrugDDI.d21.s5.e0" e2="DrugDDI.d21.s5.e1" id="DrugDDI.d21.s5.p0" interaction="false"/><negationtags>In a study involving 12 adult volunteers, TORADOLORAL was coadministered with a single dose of 25 mg warfarin, causing &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; significant changes in pharmacokinetics or pharmacodynamics of warfarin&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d21.s6" origId="s6" text="In another study, TORADOLIV/IM was given with two doses of 5000 U of heparin to 11 healthy volunteers, resulting in a mean template bleeding time of 6.4 minutes (3.2 to 11.4 min) compared to a mean of 6.0 minutes (3.4 to 7.5 min) for heparin alone and 5.1 minutes (3.5 to 8.5 min) for placebo."><entity charOffset="69-76" id="DrugDDI.d21.s6.e0" origId="s6.p86" text="heparin" type="drug"/><entity charOffset="234-241" id="DrugDDI.d21.s6.e1" origId="s6.p102" text="heparin" type="drug"/><pair e1="DrugDDI.d21.s6.e0" e2="DrugDDI.d21.s6.e1" id="DrugDDI.d21.s6.p0" interaction="false"/></sentence><sentence id="DrugDDI.d21.s7" origId="s7" text="Although these results do not indicate a significant interaction between TORADOL and warfarin or heparin, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored."><entity charOffset="73-80" id="DrugDDI.d21.s7.e0" origId="s7.p116" text="TORADOL" type="drug"/><entity charOffset="85-93" id="DrugDDI.d21.s7.e1" origId="s7.p118" text="warfarin" type="drug"/><entity charOffset="97-104" id="DrugDDI.d21.s7.e2" origId="s7.p120" text="heparin" type="drug"/><entity charOffset="128-135" id="DrugDDI.d21.s7.e3" origId="s7.p122" text="TORADOL" type="drug"/><entity charOffset="155-169" id="DrugDDI.d21.s7.e4" origId="s7.p125" text="anticoagulants" type="drug"/><pair e1="DrugDDI.d21.s7.e0" e2="DrugDDI.d21.s7.e1" id="DrugDDI.d21.s7.p0" interaction="false"/><pair e1="DrugDDI.d21.s7.e0" e2="DrugDDI.d21.s7.e2" id="DrugDDI.d21.s7.p1" interaction="false"/><pair e1="DrugDDI.d21.s7.e0" e2="DrugDDI.d21.s7.e3" id="DrugDDI.d21.s7.p2" interaction="false"/><pair e1="DrugDDI.d21.s7.e0" e2="DrugDDI.d21.s7.e4" id="DrugDDI.d21.s7.p3" interaction="false"/><pair e1="DrugDDI.d21.s7.e1" e2="DrugDDI.d21.s7.e2" id="DrugDDI.d21.s7.p4" interaction="false"/><pair e1="DrugDDI.d21.s7.e1" e2="DrugDDI.d21.s7.e3" id="DrugDDI.d21.s7.p5" interaction="false"/><pair e1="DrugDDI.d21.s7.e1" e2="DrugDDI.d21.s7.e4" id="DrugDDI.d21.s7.p6" interaction="false"/><pair e1="DrugDDI.d21.s7.e2" e2="DrugDDI.d21.s7.e3" id="DrugDDI.d21.s7.p7" interaction="false"/><pair e1="DrugDDI.d21.s7.e2" e2="DrugDDI.d21.s7.e4" id="DrugDDI.d21.s7.p8" interaction="false"/><pair e1="DrugDDI.d21.s7.e3" e2="DrugDDI.d21.s7.e4" id="DrugDDI.d21.s7.p9" interaction="true"/><negationtags>Although these results do &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; indicate a significant interaction between TORADOL and warfarin or heparin&lt;/xcope&gt;, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.</negationtags></sentence><sentence id="DrugDDI.d21.s8" origId="s8" text="Furosemide TORADOLIV/IM reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%)."><entity charOffset="0-21" id="DrugDDI.d21.s8.e0" origId="s8.p136" text="Furosemide TORADOLIV" type="drug"/><entity charOffset="36-44" id="DrugDDI.d21.s8.e1" origId="s8.p139" text="diuretic" type="drug"/><entity charOffset="57-68" id="DrugDDI.d21.s8.e2" origId="s8.p140" text="furosemide" type="drug"/><entity charOffset="128-134" id="DrugDDI.d21.s8.e3" origId="s8.p144" text="sodium" type="drug"/><pair e1="DrugDDI.d21.s8.e0" e2="DrugDDI.d21.s8.e1" id="DrugDDI.d21.s8.p0" interaction="false"/><pair e1="DrugDDI.d21.s8.e0" e2="DrugDDI.d21.s8.e2" id="DrugDDI.d21.s8.p1" interaction="true"/><pair e1="DrugDDI.d21.s8.e0" e2="DrugDDI.d21.s8.e3" id="DrugDDI.d21.s8.p2" interaction="false"/><pair e1="DrugDDI.d21.s8.e1" e2="DrugDDI.d21.s8.e2" id="DrugDDI.d21.s8.p3" interaction="false"/><pair e1="DrugDDI.d21.s8.e1" e2="DrugDDI.d21.s8.e3" id="DrugDDI.d21.s8.p4" interaction="false"/><pair e1="DrugDDI.d21.s8.e2" e2="DrugDDI.d21.s8.e3" id="DrugDDI.d21.s8.p5" interaction="false"/></sentence><sentence id="DrugDDI.d21.s9" origId="s9" text="Probenecid Concomitant administration of TORADOLORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours."><entity charOffset="0-10" id="DrugDDI.d21.s9.e0" origId="s9.p150" text="Probenecid" type="drug"/><entity charOffset="57-67" id="DrugDDI.d21.s9.e1" origId="s9.p153" text="probenecid" type="drug"/><entity charOffset="103-112" id="DrugDDI.d21.s9.e2" origId="s9.p156" text="ketorolac" type="drug"/><entity charOffset="142-151" id="DrugDDI.d21.s9.e3" origId="s9.p159" text="ketorolac" type="drug"/><pair e1="DrugDDI.d21.s9.e0" e2="DrugDDI.d21.s9.e1" id="DrugDDI.d21.s9.p0" interaction="true"/><pair e1="DrugDDI.d21.s9.e0" e2="DrugDDI.d21.s9.e2" id="DrugDDI.d21.s9.p1" interaction="false"/><pair e1="DrugDDI.d21.s9.e0" e2="DrugDDI.d21.s9.e3" id="DrugDDI.d21.s9.p2" interaction="false"/><pair e1="DrugDDI.d21.s9.e1" e2="DrugDDI.d21.s9.e2" id="DrugDDI.d21.s9.p3" interaction="false"/><pair e1="DrugDDI.d21.s9.e1" e2="DrugDDI.d21.s9.e3" id="DrugDDI.d21.s9.p4" interaction="false"/><pair e1="DrugDDI.d21.s9.e2" e2="DrugDDI.d21.s9.e3" id="DrugDDI.d21.s9.p5" interaction="false"/></sentence><sentence id="DrugDDI.d21.s10" origId="s10" text="Therefore, concomitant use of TORADOL and probenecid is contraindicated."><entity charOffset="30-37" id="DrugDDI.d21.s10.e0" origId="s10.p177" text="TORADOL" type="drug"/><entity charOffset="42-52" id="DrugDDI.d21.s10.e1" origId="s10.p179" text="probenecid" type="drug"/><pair e1="DrugDDI.d21.s10.e0" e2="DrugDDI.d21.s10.e1" id="DrugDDI.d21.s10.p0" interaction="true"/></sentence><sentence id="DrugDDI.d21.s11" origId="s11" text="Lithium Inhibition of renal lithium clearance, leading to an increase in plasma lithium concentration, has been reported with some prostaglandin synthesis-inhibiting drugs."><entity charOffset="0-7" id="DrugDDI.d21.s11.e0" origId="s11.p182" text="Lithium" type="drug"/><entity charOffset="28-35" id="DrugDDI.d21.s11.e1" origId="s11.p183" text="lithium" type="drug"/><entity charOffset="80-87" id="DrugDDI.d21.s11.e2" origId="s11.p186" text="lithium" type="drug"/><entity charOffset="131-144" id="DrugDDI.d21.s11.e3" origId="s11.p190" text="prostaglandin" type="drug"/><entity charOffset="166-171" id="DrugDDI.d21.s11.e4" origId="s11.p192" text="drugs" type="drug"/><pair e1="DrugDDI.d21.s11.e0" e2="DrugDDI.d21.s11.e1" id="DrugDDI.d21.s11.p0" interaction="false"/><pair e1="DrugDDI.d21.s11.e0" e2="DrugDDI.d21.s11.e2" id="DrugDDI.d21.s11.p1" interaction="false"/><pair e1="DrugDDI.d21.s11.e0" e2="DrugDDI.d21.s11.e3" id="DrugDDI.d21.s11.p2" interaction="true"/><pair e1="DrugDDI.d21.s11.e0" e2="DrugDDI.d21.s11.e4" id="DrugDDI.d21.s11.p3" interaction="false"/><pair e1="DrugDDI.d21.s11.e1" e2="DrugDDI.d21.s11.e2" id="DrugDDI.d21.s11.p4" interaction="false"/><pair e1="DrugDDI.d21.s11.e1" e2="DrugDDI.d21.s11.e3" id="DrugDDI.d21.s11.p5" interaction="false"/><pair e1="DrugDDI.d21.s11.e1" e2="DrugDDI.d21.s11.e4" id="DrugDDI.d21.s11.p6" interaction="false"/><pair e1="DrugDDI.d21.s11.e2" e2="DrugDDI.d21.s11.e3" id="DrugDDI.d21.s11.p7" interaction="false"/><pair e1="DrugDDI.d21.s11.e2" e2="DrugDDI.d21.s11.e4" id="DrugDDI.d21.s11.p8" interaction="false"/><pair e1="DrugDDI.d21.s11.e3" e2="DrugDDI.d21.s11.e4" id="DrugDDI.d21.s11.p9" interaction="false"/></sentence><sentence id="DrugDDI.d21.s12" origId="s12" text="The effect of TORADOL on plasma lithium has not been studied, but cases of increased lithium plasma levels during TORADOL therapy have been reported."><entity charOffset="14-21" id="DrugDDI.d21.s12.e0" origId="s12.p194" text="TORADOL" type="drug"/><entity charOffset="32-39" id="DrugDDI.d21.s12.e1" origId="s12.p195" text="lithium" type="drug"/><entity charOffset="114-121" id="DrugDDI.d21.s12.e2" origId="s12.p204" text="TORADOL" type="drug"/><pair e1="DrugDDI.d21.s12.e0" e2="DrugDDI.d21.s12.e1" id="DrugDDI.d21.s12.p0" interaction="false"/><pair e1="DrugDDI.d21.s12.e0" e2="DrugDDI.d21.s12.e2" id="DrugDDI.d21.s12.p1" interaction="false"/><pair e1="DrugDDI.d21.s12.e1" e2="DrugDDI.d21.s12.e2" id="DrugDDI.d21.s12.p2" interaction="true"/><negationtags>The effect of TORADOL on plasma lithium has &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; been studied&lt;/xcope&gt;, but cases of increased lithium plasma levels during TORADOL therapy have been reported.</negationtags></sentence><sentence id="DrugDDI.d21.s13" origId="s13" text="Methotrexate Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate."><entity charOffset="0-12" id="DrugDDI.d21.s13.e0" origId="s13.p208" text="Methotrexate" type="drug"/><entity charOffset="43-55" id="DrugDDI.d21.s13.e1" origId="s13.p209" text="methotrexate" type="drug"/><entity charOffset="65-71" id="DrugDDI.d21.s13.e2" origId="s13.p211" text="NSAIDs" type="drug"/><entity charOffset="117-129" id="DrugDDI.d21.s13.e3" origId="s13.p218" text="methotrexate" type="drug"/><entity charOffset="157-169" id="DrugDDI.d21.s13.e4" origId="s13.p221" text="methotrexate" type="drug"/><pair e1="DrugDDI.d21.s13.e0" e2="DrugDDI.d21.s13.e1" id="DrugDDI.d21.s13.p0" interaction="false"/><pair e1="DrugDDI.d21.s13.e0" e2="DrugDDI.d21.s13.e2" id="DrugDDI.d21.s13.p1" interaction="false"/><pair e1="DrugDDI.d21.s13.e0" e2="DrugDDI.d21.s13.e3" id="DrugDDI.d21.s13.p2" interaction="false"/><pair e1="DrugDDI.d21.s13.e0" e2="DrugDDI.d21.s13.e4" id="DrugDDI.d21.s13.p3" interaction="false"/><pair e1="DrugDDI.d21.s13.e1" e2="DrugDDI.d21.s13.e2" id="DrugDDI.d21.s13.p4" interaction="true"/><pair e1="DrugDDI.d21.s13.e1" e2="DrugDDI.d21.s13.e3" id="DrugDDI.d21.s13.p5" interaction="false"/><pair e1="DrugDDI.d21.s13.e1" e2="DrugDDI.d21.s13.e4" id="DrugDDI.d21.s13.p6" interaction="false"/><pair e1="DrugDDI.d21.s13.e2" e2="DrugDDI.d21.s13.e3" id="DrugDDI.d21.s13.p7" interaction="false"/><pair e1="DrugDDI.d21.s13.e2" e2="DrugDDI.d21.s13.e4" id="DrugDDI.d21.s13.p8" interaction="false"/><pair e1="DrugDDI.d21.s13.e3" e2="DrugDDI.d21.s13.e4" id="DrugDDI.d21.s13.p9" interaction="false"/></sentence><sentence id="DrugDDI.d21.s14" origId="s14" text="The effect of TORADOL on methotrexate clearance has not been studied."><entity charOffset="14-21" id="DrugDDI.d21.s14.e0" origId="s14.p223" text="TORADOL" type="drug"/><entity charOffset="25-37" id="DrugDDI.d21.s14.e1" origId="s14.p224" text="methotrexate" type="drug"/><pair e1="DrugDDI.d21.s14.e0" e2="DrugDDI.d21.s14.e1" id="DrugDDI.d21.s14.p0" interaction="false"/><negationtags>&lt;xcope&gt;The effect of TORADOL on methotrexate clearance has &lt;cue&gt;not&lt;/cue&gt; been studied&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d21.s15" origId="s15" text="Nondepolarizing Muscle Relaxants In postmarketing experience there have been reports of a possible interaction between TORADOLIV/IM and nondepolarizing muscle relaxants that resulted in apnea."><entity charOffset="16-32" id="DrugDDI.d21.s15.e0" origId="s15.p229" text="Muscle Relaxants" type="drug"/><entity charOffset="152-168" id="DrugDDI.d21.s15.e1" origId="s15.p240" text="muscle relaxants" type="drug"/><pair e1="DrugDDI.d21.s15.e0" e2="DrugDDI.d21.s15.e1" id="DrugDDI.d21.s15.p0" interaction="false"/></sentence><sentence id="DrugDDI.d21.s16" origId="s16" text="The concurrent use of TORADOL with muscle relaxants has not been formally studied."><entity charOffset="22-29" id="DrugDDI.d21.s16.e0" origId="s16.p245" text="TORADOL" type="drug"/><entity charOffset="35-51" id="DrugDDI.d21.s16.e1" origId="s16.p246" text="muscle relaxants" type="drug"/><pair e1="DrugDDI.d21.s16.e0" e2="DrugDDI.d21.s16.e1" id="DrugDDI.d21.s16.p0" interaction="false"/><negationtags>&lt;xcope&gt;The concurrent use of TORADOL with muscle relaxants has &lt;cue&gt;not&lt;/cue&gt; been formally studied&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d21.s17" origId="s17" text="ACE Inhibitors Concomitant use of ACE inhibitors may increase the risk of renal impairment, particularly in volume-depleted patients."><entity charOffset="0-14" id="DrugDDI.d21.s17.e0" origId="s17.p252" text="ACE Inhibitors" type="drug"/><entity charOffset="34-48" id="DrugDDI.d21.s17.e1" origId="s17.p253" text="ACE inhibitors" type="drug"/><pair e1="DrugDDI.d21.s17.e0" e2="DrugDDI.d21.s17.e1" id="DrugDDI.d21.s17.p0" interaction="false"/></sentence><sentence id="DrugDDI.d21.s18" origId="s18" text="Antiepileptic Drugs Sporadic cases of seizures have been reported during concomitant use of TORADOL and antiepileptic drugs (phenytoin, carbamazepine)."><entity charOffset="0-19" id="DrugDDI.d21.s18.e0" origId="s18.p260" text="Antiepileptic Drugs" type="drug"/><entity charOffset="92-99" id="DrugDDI.d21.s18.e1" origId="s18.p266" text="TORADOL" type="drug"/><entity charOffset="104-123" id="DrugDDI.d21.s18.e2" origId="s18.p268" text="antiepileptic drugs" type="drug"/><entity charOffset="125-134" id="DrugDDI.d21.s18.e3" origId="s18.p270" text="phenytoin" type="drug"/><entity charOffset="136-149" id="DrugDDI.d21.s18.e4" origId="s18.p271" text="carbamazepine" type="drug"/><pair e1="DrugDDI.d21.s18.e0" e2="DrugDDI.d21.s18.e1" id="DrugDDI.d21.s18.p0" interaction="false"/><pair e1="DrugDDI.d21.s18.e0" e2="DrugDDI.d21.s18.e2" id="DrugDDI.d21.s18.p1" interaction="false"/><pair e1="DrugDDI.d21.s18.e0" e2="DrugDDI.d21.s18.e3" id="DrugDDI.d21.s18.p2" interaction="false"/><pair e1="DrugDDI.d21.s18.e0" e2="DrugDDI.d21.s18.e4" id="DrugDDI.d21.s18.p3" interaction="false"/><pair e1="DrugDDI.d21.s18.e1" e2="DrugDDI.d21.s18.e2" id="DrugDDI.d21.s18.p4" interaction="true"/><pair e1="DrugDDI.d21.s18.e1" e2="DrugDDI.d21.s18.e3" id="DrugDDI.d21.s18.p5" interaction="false"/><pair e1="DrugDDI.d21.s18.e1" e2="DrugDDI.d21.s18.e4" id="DrugDDI.d21.s18.p6" interaction="true"/><pair e1="DrugDDI.d21.s18.e2" e2="DrugDDI.d21.s18.e3" id="DrugDDI.d21.s18.p7" interaction="false"/><pair e1="DrugDDI.d21.s18.e2" e2="DrugDDI.d21.s18.e4" id="DrugDDI.d21.s18.p8" interaction="false"/><pair e1="DrugDDI.d21.s18.e3" e2="DrugDDI.d21.s18.e4" id="DrugDDI.d21.s18.p9" interaction="false"/></sentence><sentence id="DrugDDI.d21.s19" origId="s19" text="Psychoactive Drugs Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam)."><entity charOffset="0-18" id="DrugDDI.d21.s19.e0" origId="s19.p273" text="Psychoactive Drugs" type="drug"/><entity charOffset="58-65" id="DrugDDI.d21.s19.e1" origId="s19.p278" text="TORADOL" type="drug"/><entity charOffset="94-112" id="DrugDDI.d21.s19.e2" origId="s19.p283" text="psychoactive drugs" type="drug"/><entity charOffset="114-124" id="DrugDDI.d21.s19.e3" origId="s19.p285" text="fluoxetine" type="drug"/><entity charOffset="126-137" id="DrugDDI.d21.s19.e4" origId="s19.p286" text="thiothixene" type="drug"/><entity charOffset="139-149" id="DrugDDI.d21.s19.e5" origId="s19.p287" text="alprazolam" type="drug"/><pair e1="DrugDDI.d21.s19.e0" e2="DrugDDI.d21.s19.e1" id="DrugDDI.d21.s19.p0" interaction="false"/><pair e1="DrugDDI.d21.s19.e0" e2="DrugDDI.d21.s19.e2" id="DrugDDI.d21.s19.p1" interaction="false"/><pair e1="DrugDDI.d21.s19.e0" e2="DrugDDI.d21.s19.e3" id="DrugDDI.d21.s19.p2" interaction="false"/><pair e1="DrugDDI.d21.s19.e0" e2="DrugDDI.d21.s19.e4" id="DrugDDI.d21.s19.p3" interaction="false"/><pair e1="DrugDDI.d21.s19.e0" e2="DrugDDI.d21.s19.e5" id="DrugDDI.d21.s19.p4" interaction="false"/><pair e1="DrugDDI.d21.s19.e1" e2="DrugDDI.d21.s19.e2" id="DrugDDI.d21.s19.p5" interaction="true"/><pair e1="DrugDDI.d21.s19.e1" e2="DrugDDI.d21.s19.e3" id="DrugDDI.d21.s19.p6" interaction="false"/><pair e1="DrugDDI.d21.s19.e1" e2="DrugDDI.d21.s19.e4" id="DrugDDI.d21.s19.p7" interaction="true"/><pair e1="DrugDDI.d21.s19.e1" e2="DrugDDI.d21.s19.e5" id="DrugDDI.d21.s19.p8" interaction="false"/><pair e1="DrugDDI.d21.s19.e2" e2="DrugDDI.d21.s19.e3" id="DrugDDI.d21.s19.p9" interaction="false"/><pair e1="DrugDDI.d21.s19.e2" e2="DrugDDI.d21.s19.e4" id="DrugDDI.d21.s19.p10" interaction="false"/><pair e1="DrugDDI.d21.s19.e2" e2="DrugDDI.d21.s19.e5" id="DrugDDI.d21.s19.p11" interaction="false"/><pair e1="DrugDDI.d21.s19.e3" e2="DrugDDI.d21.s19.e4" id="DrugDDI.d21.s19.p12" interaction="false"/><pair e1="DrugDDI.d21.s19.e3" e2="DrugDDI.d21.s19.e5" id="DrugDDI.d21.s19.p13" interaction="false"/><pair e1="DrugDDI.d21.s19.e4" e2="DrugDDI.d21.s19.e5" id="DrugDDI.d21.s19.p14" interaction="false"/></sentence><sentence id="DrugDDI.d21.s20" origId="s20" text="Morphine TORADOLIV/IM has been administered concurrently with morphine in several clinical trials of postoperative pain without evidence of adverse interactions."><entity charOffset="0-8" id="DrugDDI.d21.s20.e0" origId="s20.p289" text="Morphine" type="drug"/><entity charOffset="62-70" id="DrugDDI.d21.s20.e1" origId="s20.p295" text="morphine" type="drug"/><pair e1="DrugDDI.d21.s20.e0" e2="DrugDDI.d21.s20.e1" id="DrugDDI.d21.s20.p0" interaction="true"/><negationtags>Morphine TORADOLIV/IM has been administered concurrently with morphine in several clinical trials of postoperative pain &lt;xcope&gt;&lt;cue&gt;without&lt;/cue&gt; evidence of adverse interactions&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d21.s21" origId="s21" text="Do not mix TORADOL and morphine in the same syringe."><entity charOffset="11-18" id="DrugDDI.d21.s21.e0" origId="s21.p303" text="TORADOL" type="drug"/><entity charOffset="23-31" id="DrugDDI.d21.s21.e1" origId="s21.p305" text="morphine" type="drug"/><pair e1="DrugDDI.d21.s21.e0" e2="DrugDDI.d21.s21.e1" id="DrugDDI.d21.s21.p0" interaction="true"/><negationtags>Do &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; mix TORADOL and morphine in the same syringe&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d21.s22" origId="s22" text="There is no evidence in animal or human studies that TORADOL induces or inhibits hepatic enzymes capable of metabolizing itself or other drugs"><entity charOffset="53-60" id="DrugDDI.d21.s22.e0" origId="s22.p314" text="TORADOL" type="drug"/><entity charOffset="137-142" id="DrugDDI.d21.s22.e1" origId="s22.p322" text="drugs" type="drug"/><pair e1="DrugDDI.d21.s22.e0" e2="DrugDDI.d21.s22.e1" id="DrugDDI.d21.s22.p0" interaction="false"/><negationtags>There is &lt;xcope&gt;&lt;cue&gt;no&lt;/cue&gt; evidence in animal or human studies that TORADOL induces or inhibits hepatic enzymes capable of metabolizing itself or other drugs&lt;/xcope&gt;</negationtags></sentence><sentence id="DrugDDI.d21.s23" origId="s23" text="."/><sentence id="DrugDDI.d21.s24" origId="s24" text="?"/></document>